Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

2019/11/19 by C. Quintarelli, Concetta Quintarelli, S. Sivori +43 · 2 citations
Medicine · Immunology and Microbiology · #CAR-T cell therapy research #Immune Cell Function and Interaction #T-cell and B-cell Immunology

paper · doi:10.1038/s41375-019-0613-7

Cited by

• Chimeric antigen receptor natural killer cell therapy: A systematic review of preclinical studies for hematologic and solid malignancies
• Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks